ARENA PHARMACEUTICALS INC's ticker is ARNA and the CUSIP is 040047607. A total of 2 filers reported holding ARENA PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $418,000 | +56.0% | 4,500 | 0.0% | 0.01% | +50.0% |
| Q3 2021 | $268,000 | -12.7% | 4,500 | 0.0% | 0.01% | 0.0% |
| Q2 2021 | $307,000 | -1.6% | 4,500 | 0.0% | 0.01% | -14.3% |
| Q1 2021 | $312,000 | -9.8% | 4,500 | 0.0% | 0.01% | -41.7% |
| Q4 2020 | $346,000 | +2.7% | 4,500 | 0.0% | 0.01% | -14.3% |
| Q3 2020 | $337,000 | +19.1% | 4,500 | 0.0% | 0.01% | +40.0% |
| Q2 2020 | $283,000 | +38.7% | 4,500 | 0.0% | 0.01% | +66.7% |
| Q4 2019 | $204,000 | -1.0% | 4,500 | 0.0% | 0.01% | 0.0% |
| Q3 2019 | $206,000 | -22.0% | 4,500 | 0.0% | 0.01% | -14.3% |
| Q2 2019 | $264,000 | +30.7% | 4,500 | 0.0% | 0.01% | +16.7% |
| Q1 2019 | $202,000 | – | 4,500 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 139,528 | $6,083,000 | 4.46% |
| Eversept Partners, LP | 134,151 | $5,848,984 | 2.68% |
| DAFNA Capital Management LLC | 95,242 | $4,153,000 | 1.94% |
| GREAT POINT PARTNERS LLC | 302,000 | $13,167,000 | 1.82% |
| Atika Capital Management LLC | 190,000 | $8,284,000 | 1.59% |
| Crawford Lake Capital Management, LLC | 205,600 | $8,964,000 | 1.57% |
| Crawford Lake Capital Management, LLC | 205,688 | $8,968,000 | 1.57% |
| Cormorant Asset Management, LP | 450,000 | $19,620,000 | 1.45% |
| SENZAR ASSET MANAGEMENT, LLC | 11,123 | $485,000 | 1.40% |
| Rhenman & Partners Asset Management AB | 284,621 | $12,409,000 | 1.27% |